AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2012
Dec 5, 2012
29745_dirs_2012-12-05_c0ea6875-424b-4b10-ac06-76f721e41741.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-12-03
Reporting Person: Ricks David A (SVP and Pres, Lilly Bio-Meds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-03 | Common Stock | M | 2748 | $0.00 | Acquired | 19632 | Direct |
| 2012-12-03 | Common Stock | F | 865 | $49.04 | Disposed | 18767 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-03 | Restricted Stock Unit | $0.00 | M | 2748 | Disposed | 2012-12-03 | Common Stock (2748) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2098 | Indirect |
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29